17 January 2025

Champalimaud Foundation: 20 years at the service of humanity

From groundbreaking scientific research to compassionate, patient-centered clinical care, the Foundation is committed to developing innovative solutions for complex challenges, all with the goal of improving lives and inspiring hope.

Founded in the beginning of the 21st century, it carries forward the visionary legacy of António Champalimaud, advancing science and healthcare for the greater good of humanity.

Join us in discovering how, together, we are shaping a brighter future.

16 January 2025

Eavesdropping on organs: immune system controls blood sugar levels

During periods of low energy—such as intermittent fasting or exercise—immune cells step in to regulate blood sugar levels, acting as the “postman” in a previously unknown three-way conversation between the nervous, immune and hormonal systems. These findings open up new approaches for managing conditions like diabetes, obesity, and cancer.

Champalimaud Open Seminars: Carlos Minutti

Date and time:

20 January 2025 – 12:00

Location:

Champalimaud Foundation Auditorium

Description:

Conventional Dendritic Cells – Ecology, Diversity, and Functio

Carlos Minutti (Immunoregulation Lab)


Moderator: Cristina João (Myeloma Lymphoma Research Group)

 

Understanding and Harnessing Cancer Immunity: From Biology to Therapy

Host

Rita Fior, PhD, Cancer Development and Innate Immune Evasion Lab


Venue

Seminar room

15 Jan. 2025

Programme Manager - Breast Cancer Research Programme

Clinical Centre
Application Starts: 15 Jan. 2025

Program Overview

The Champalimaud Foundation Breast Cancer Research Program - is dedicated to advancing the understanding, prevention, and treatment of breast cancer. The program integrates cutting-edge research with community engagement and education to improve outcomes for those affected by breast cancer.

15 Jan. 2025

Health Data Engineer - Breast Cancer Research Programme

Clinical Centre
Application Starts: 15 Jan. 2025

Program Overview

The Breast Cancer Research Program at the Champalimaud Foundation is dedicated to advancing the understanding, prevention, and treatment of breast cancer. The program integrates cutting-edge research with community engagement and education to improve outcomes for those affected by breast cancer.

14 January 2025

Researchers uncover what drives aggressive bone cancer

Osteosarcoma is a type of aggressive bone cancer that most commonly affects children and young adults between the ages of 10 and 20, during times of rapid bone growth. Although rare, it has a significant impact on young people and their families as treatment can require surgery or amputation. The cancer also has the potential to spread to other organs, most commonly the lungs. Because osteosarcoma is so genomically complex, it has been challenging to identify what genetic mutations drive the disease.

Is Love Blind? Mating Proximity Gates Threat Perception

Host

Daniel Münch, PhD, Behaviour and Metabolism Lab


Venue

Seminar room

19 Dec. 2024

Research Technician 2025 - Sánchez-Danés lab

Research
Application Starts: 19 Dec. 2024

The Champalimaud Foundation (Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud), a private, non-profit research institution in Lisbon, Portugal, is looking for a Research technician to join our team at the Champalimaud Research Program. 

The selected candidate will participate in running in vivo and in vitro experiments aimed at studying the mechanisms involved in cancer formation. This position will include a broad and evolving range of tasks, including:

09 January 2025

The state of water? Alarming

Water is the matrix of our planet. Not only human societies, but all forms of life, are dependent on water. And while we still take its availability largely for granted, it is a resource which is becoming scarcer by the minute owing to climate change,  intensive agriculture, and access inequalities to water for drinking, cooking, and personal hygiene.

Subscribe to Research Groups
Loading
Please wait...